A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
176 patients around the world
Available in United States, Brazil
Vertex Pharmaceuticals Incorporated
1Research sites
176Patients around the world
This study is for people with
Nephropathy
Idiopathic membranous nephropathy
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Diagnosed with pMN with confirmatory historical biopsy. If no historical biopsy was performed that confirmed pMN, a biopsy can be performed during Screening to confirm eligibility.
Hypersensitivity to investigational medicinal product or to any of its excipients.
Sites
Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP
Recruiting
Rua Dr. Ovídio Pires de Campos 785 - Estado de São Paulo 05403-000
